{
  "id": 20661719,
  "title": "Quadruple Agonist Reduced Weight Without Major Muscle Loss in Mid-Stage Trial",
  "url": "https://urgent.news/2026/11/18/quadruple-agonist-reduced-weight-without-major-muscle-loss-in-mid",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-11-18T20:41:52.000Z",
  "source": {
    "name": "MedPage Today",
    "slug": "medpage-today",
    "url": "https://www.medpagetoday.com/meetingcoverage/obesityweek/123955"
  },
  "original_language": "en",
  "account": null,
  "summary": "(MedPage Today) -- NATIONAL HARBOR, Md. -- An investigational oral quadruple receptor agonist led to substantial weight loss with preservation of lean mass, a randomized phase II trial presented here showed. By week 13, the two highest tested...",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}